These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4859518)

  • 1. Synthesis of oxytocin and related diastereomers deuterated in the half-cystine positions. Comparison of solid-phase and solution methods.
    Spatola AF; Cornelius DA; Hruby VJ; Blomquist AT
    J Org Chem; 1974 Jul; 39(15):2207-12. PubMed ID: 4859518
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of specifically deuterated S-benzylcysteines and of oxytocin and related diastereomers deuterated in the half-cystine positions.
    Upson DA; Hruby VJ
    J Org Chem; 1976 Apr; 41(8):1353-8. PubMed ID: 1263005
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S; Schwartz IL; Walter R
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract]   [Full Text] [Related]  

  • 5. Solid-phase synthesis of (2-isoleucine, 4-leucine) oxytocin and (2-phenylalanine, 4-leucine) oxytocin and some their pharmacological properties.
    Hruby VJ; Muscio F; Gronginsky CM; Gitu PM; Saba D; Chan WY
    J Med Chem; 1973 Jun; 16(6):624-9. PubMed ID: 4733119
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of (1,6-alpha,alpha'-diaminosuberic acid)oxytocin ('dicarba-oxytocin').
    Keller O; Rudinger J
    Helv Chim Acta; 1974; 57(5):1253-9. PubMed ID: 4854571
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of (1-(L-2-hydroxy-3-mercaptopropanoic acid))oxytocin, a highly potent analogue of oxytocin.
    Wälti M; Hope DB
    J Chem Soc Perkin 1; 1972; 15():1946-50. PubMed ID: 4672381
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties.
    Yamanaka T; Hase S; Sakakibara S; Schwartz IL; Dubois BM; Walter R
    Mol Pharmacol; 1970 Sep; 6(5):474-80. PubMed ID: 5466703
    [No Abstract]   [Full Text] [Related]  

  • 9. Solid phase synthesis of (3,4-dileucine)-oxytocin and a study of some of its pharmacological properties.
    Wille MA; Cahn WY; Du Vigneaud V
    J Med Chem; 1972 Jan; 15(1):11-2. PubMed ID: 5061981
    [No Abstract]   [Full Text] [Related]  

  • 10. Solid-phase synthesis of (4-threonine)-oxytocin. A more potent and specific oxytocic agent than oxytocin.
    Manning M; Coy E; Sawyer WH
    Biochemistry; 1970 Sep; 9(20):3925-30. PubMed ID: 5533681
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and some pharmacological properties of (1-deamino,9-thioglycine)oxytocin.
    Jones WC; Nestor JJ; Du Vigneaud V
    J Am Chem Soc; 1973 Aug; 95(17):5677-9. PubMed ID: 4733810
    [No Abstract]   [Full Text] [Related]  

  • 12. Unequivocal assignments of NH proton magnetic resonance bands in oxytocin using 2H- and 15N-substituted molecules.
    Bradbury AF; Burgen AS; Feeney J; Roberts GC; Smyth DG
    FEBS Lett; 1974 Jun; 42(2):179-82. PubMed ID: 4855316
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin.
    Hase S; Sakakibara S; Wahrenburg M; Walter R
    J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of an analogue of the peptide hormone oxytocin that contains a mimetic of an inverse gamma-turn.
    Yuan Z; Blomberg D; Sethson I; Brickmann K; Ekholm K; Johansson B; Nilsson A; Kihlberg J
    J Med Chem; 2002 Jun; 45(12):2512-9. PubMed ID: 12036359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of oxytocin-(1-6)-hexapeptide amide, vasopressin-(1-6)-hexapeptide amide and their deamino analogues.
    Krejcí I; Barth T; Kupková B; Fruhaufová L; Flegel M; Zaoral M
    Eur J Pharmacol; 1973 Nov; 24(2):179-82. PubMed ID: 4797284
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues).
    Barth T; Krejcí I; Kupková B; Jost K
    Eur J Pharmacol; 1973 Nov; 24(2):183-8. PubMed ID: 4797285
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of magnesium on the response of the rat mammary gland strip to oxytocin analogues.
    Polácek I; Krejci I
    Eur J Pharmacol; 1969 Jul; 7(1):85-8. PubMed ID: 5387670
    [No Abstract]   [Full Text] [Related]  

  • 18. Four cyclic disulfide pentapeptides possessing the ring of isotocin and glumitocin.
    Smith CW; Hruby VJ; Ferger MF
    J Med Chem; 1974 Aug; 17(8):873-6. PubMed ID: 4858613
    [No Abstract]   [Full Text] [Related]  

  • 19. The deamino derivatives of (4-threonine)-oxytocin and (4-threonine)-mesotocin; analogs possessing a surprising spectrum of diminished pharmacological activities.
    Manning M; Coy EJ; Sawyer WH
    Experientia; 1971; 27(11):1372-4. PubMed ID: 5167408
    [No Abstract]   [Full Text] [Related]  

  • 20. Deuterated oxytocins: the synthesis and biological properties of a crystalline analog of deamino-oxytocin deuterated in the 5-asparagine position.
    Blomquist AT; Rich DH; Carlson BA; Allen GA; Hruby VJ; Takashima H; Nangeroni LL; Glose P; Du Vigneaud V
    Proc Natl Acad Sci U S A; 1969 Sep; 64(1):263-6. PubMed ID: 5263009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.